Events

Upcoming Events

Morgan Stanley 21st Annual Global Healthcare Conference
September 11-13, 2023

UBS Biotechnology Private Company Virtual Symposium
September 20-21, 2023

Past Events

Jeffries Global Healthcare Conference
Jun. 7-9, 2023

RBC Global Healthcare Conference
May. 16-17, 2023

22nd Annual Needham Virtual Healthcare Conference
Apr. 17-20, 2023

2023 Stifel CNS Days Conference, Virtual
Mar. 28-29, 2023

Gordon Research Conference (GRC)
Mar. 5-10, 2023

SFN 2022 Neuroscience Annual Meeting
Nov. 12-16, 2022

Bank of America Private Company Showcase
Oct. 20, 2022

2nd Annual Needham Biotech Private Company Virtual 1×1 Forum
Oct. 18-19, 2022

Oppenheimer’s Private Company Showcase
Oct. 17-18, 2022

BMO Life Sciences Private Company Showcase
Oct. 13, 2022

Cantor Fitzgerald Neurology & Psychiatry Conference
Oct. 6, 2022

UBS Virtual Biotechnology Forum
Sept. 21-22, 2022

2022 Jefferies Global Healthcare Conference
June 8-10, 2022

UBS Global Healthcare Conference
May 25, 2022

RBC Capital Markets Global Healthcare Conference
May 18, 2022

Needham Global Healthcare Conference
April 11-14, 2022

Stifel CNS Days
March 28, 2022

News

September 7, 2023

Pipeline Therapeutics to Participate in Multiple Upcoming Investor Conferences

August 1, 2023

Pipeline Therapeutics Announces First Subject Dosed with PIPE-791 in Phase 1 Study

July 27, 2023

BOLD Innovation That Matters: Episode III Podcast Interview with Carmine Stengone

June 8, 2023

Pipeline Therapeutics Receives IND Clearance from FDA to Initiate Phase 1 Study of PIPE-791

May 25, 2023

Pipeline Therapeutics to Present at the 2023 Jefferies Global Healthcare Conference

May 4, 2023

Pipeline Therapeutics to Present at the 2023 RBC Global Healthcare Conference

April 17, 2023

Pipeline Therapeutics Announces Global License and Development Agreement for Investigational Neuroscience Therapy, PIPE-307

April 12, 2023

Pipeline Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

March 21, 2023

Pipeline Therapeutics Announces Participation at the 2023 Stifel CNS Days Conference

March 6, 2023

Pipeline Therapeutics to Present Preclinical Poster on PIPE-791 at the Glial Biology: Functional Interactions Among Glia Neurons, a Gordon Research Conference (GRC)

November 8, 2022

Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting

November 1, 2022

Pipeline Therapeutics Announces Participation in Upcoming Investor Conferences in November

October 4, 2022

Pipeline Therapeutics Announces Participation in Upcoming Investor Conferences

September 8, 2022

Pipeline Therapeutics to Participate in the UBS Virtual Biotechnology Private Company Symposium

May 26, 2022

Pipeline Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference

May 11, 2022

Pipeline Therapeutics to Present at Multiple Investor Conferences in May 2022

April 5, 2022

Pipeline Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference

March 28, 2022

Pipeline Therapeutics Receives IND Clearance from FDA to Initiate Phase 1b/2a Study of PIPE-307 in Patients with Relapsing-Remitting Multiple Sclerosis 

March 14, 2022

Pipeline Therapeutics to Present at Upcoming March Investor Conferences

March 10, 2022

Pipeline Therapeutics Reports Positive Phase 1 Clinical Results for PIPE-307, a Neuroregenerative Therapeutic for the Treatment of Multiple Sclerosis

February 15, 2022

Pipeline Therapeutics Appoints Eef Schimmelpennink to its Board of Directors

November 10, 2021

Pipeline Therapeutics to Participate in the Stifel 2021 Virtual Healthcare and Jefferies London Healthcare Conferences

March 2, 2021

Pipeline Therapeutics Initiates Phase 1 Clinical Trial of PIPE-307

February 11, 2021

Pipeline Therapeutics Completes $80 Million Series C Financing

December 8, 2020

Pipeline Therapeutics to Participate in the 2020 RBC Capital Markets and SVB Leerink Private Company Conferences

December 3, 2020

Pipeline Therapeutics Appoints Julie Iwashita as Vice President of Clinical Operations

November 16, 2020

Pipeline Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

November 12, 2020

Pipeline Therapeutics to Present at Stifel 2020 Virtual Healthcare Conference

October 15, 2020

Pipeline Therapeutics Appoints Peter Slover as Chief Financial Officer

October 8, 2020

Pipeline Therapeutics to Present at BMO’s Fall Private Company Showcase 2020

September 18, 2020

Pipeline Therapeutics Appoints Lori Lyons-Williams to its Board of Directors

September 9, 2020

Pipeline Therapeutics to Present at Two Upcoming Investor Conferences

July 28, 2020

Pipeline Therapeutics to Present at Three Upcoming Investor Conferences

July 23, 2020

Pipeline Therapeutics Initiates Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing Loss

May 28, 2020

Pipeline Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference

April 9, 2020

Pipeline Therapeutics to Participate in the 19th Annual Needham Virtual Healthcare Conference

February 19, 2020

Pipeline Therapeutics to Participate in the SVB Leerink 9th Annual Global Healthcare Conference

December 18, 2019

Pipeline Therapeutics Completes $30 Million Series B Financing

November 13, 2019

Pipeline Therapeutics to Participate in the Stifel 2019 Healthcare Conference

October 20, 2019

Pipeline Therapeutics to present at the Society for Neuroscience’s 49th Annual Meeting in Chicago

April 6, 2018

New MS Therapy Company, Pipeline, to Focus on Rejuvenating Coating That Protects Nerve Cells